Regarding RCC, zafirlukast induces VHL- and HIF-2α-dependent oxidative cell death in ccRCC cells, which can be rescued with antioxidants and a PARP-1 inhibitor [175]. Here, EPAS1 is linked to nonpapillary renal cell carcinoma.